Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 7356 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

£5.5M Research funding to transform bowel cancer care

Cancer Research UK and partners have today committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. The team will be co-led by Professor Simon Leedham from the Nuffield Department of Medicine at the University of Oxford.

New research uncovers pathways to prevent premature cell death

New research from the Kennedy Institute has revealed how two important proteins, TBK1 and IKKe, play a crucial role in preventing premature cell death, which can lead to serious inflammation in the body. The findings are particularly relevant for people with a mutation in the TBK1 gene who often develop multiorgan inflammation caused by excessive cell death even in the absence of any infection.

Professor Asifa Majid Named 2024 AAAS Fellow

Professor Majid recognised for contributions to the understanding of language, culture, and cognition in the 2024 AAAS honours list

Making medical research work where it matters most: Global team calls for revolution in GP and community health and care trials

An international team, led the Nuffield Department of Primary Care Health Sciences, is calling for a fundamental shift in how we conduct health research to better serve our real-world health and care needs.

Oxford launches first human trial of aerosol vaccine delivery

The University of Oxford in partnership with the Coler Lab at Seattle Children’s Research Institute (SCRI) has begun a new clinical trial called TB045, which aims to test tuberculosis (TB) vaccine safety and the host immune response in a first-in-human aerosol mycobacterial challenge infection model with healthy adult volunteers.

Daily physical activity, even at light intensities, linked to lower cancer risk

A study led by researchers from Oxford Population Health has found that daily physical activity is linked to a lower risk of cancer. The number of steps taken daily may be more important for cancer risk than the intensity of activity.

One-third of antibiotics used in Vietnam are ‘inappropriate’

Ranking 11th globally in antibiotic use, Vietnam faces a serious risk of drug resistance, and could be ‘running out of treatment options due to antibiotic resistance’.

Digital test is a boost to READ-OUT biomarker study into effective ways of spotting dementia sooner

People could get the right help for the diseases that can cause dementia sooner following the announcement today of a £2 million injection of funding from the government to help spot these earlier.

Informing policy on AI in brain science and mental health

Two researchers in the Department of Psychiatry contributed to key government reports on mental health for MPs and other policy makers.

New study reveals details of key immune mechanism

An international collaboration, initiated by the Jackson Group at the MRC Weatherall Institute of Molecular Medicine, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.

New project tackles the 'undruggable' in acute leukaemia treatment

University of Oxford researcher, Katherine Vallis, has been awarded new funding from the MRC to launch a project on the use of cell-permeant antibodies for the treatment of acute leukaemia. The funding will allow Prof. Vallis and her team to generate in vivo data on the use of cell-penetrating peptides (CPPs) for cancer applications, a crucial step towards clinical translation.

Oxford marks World Tuberculosis Day as vaccine trials continue

Monday 24 March is World Tuberculosis Day. Along with its international collaborators, Oxford remains at the forefront of research to develop new vaccines to protect against this devastating disease.

New biopsy technique found to improve prostate cancer detection

Researchers from around the UK, led by the University of Oxford, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is more painful for patients.

Ancient genomic linkage regulates red blood cell development

A collaboration between the Drakesmith and Higgs Groups at the Medical Research Council Weatherall Institute of Molecular Medicine (MRC WIMM) has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.

Research shows importance of genomic testing and targeted therapies for advanced cancers

Genomic testing and targeted therapies for patients with advanced cancer could improve survival rates by up to 40%, according to researchers at the Norfolk and Norwich University Hospital, University of Adelaide and University of Oxford.

RECOVERY trial team win National Institute of Health and Care Research (NIHR) Impact Prize

Co-led by PSI Director Professor Sir Peter Horby, the RECOVERY trial was defined "one of the most well-known studies supported by the NIHR with clear national and global impact”.

Professor Michael Kidd appointed as Australia's next Chief Medical Officer

Professor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.

World Happiness Report 2025 shows people are much kinder than we expect

Belief in the kindness of others is much more closely tied to happiness than previously thought, according to World Happiness Report 2025, published by the Wellbeing Research Centre at the University of Oxford.

Research about whiplash published in two new papers

The findings come from the Neuromusculoskeletal Health and Science Lab’s whiplash cohort.

Balancing Reward with Threat Highlights the Interplay between Brain, Behaviour, and Individual Traits

Daily life involves a continuous balance between pursuing positive opportunities – rewards – and remaining vigilant to threats, a dynamic process that is critical for survival in both humans and animals.

Load More